Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16775248 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Doxycycline In Lymphangioleiomyomatosis (LAM)
Conditions: Lymphangioleiomyomatosis;   Tuberous Sclerosis
Interventions: Drug: Doxycycline;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.